Full-Time

Associate Clinical Oncology Specialist

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$110k - $130kAnnually

Junior, Mid

Naples, FL, USA + 5 more

More locations: Cape Coral, FL, USA | Fort Myers, FL, USA | Bonita Springs, FL, USA | Ellenton, FL, USA | Sarasota, FL, USA

Territory includes Naples and other key cities such as Fort Myers, Cape Coral, Sarasota, Bonita Springs, and Bradenton.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree preferred or Associate’s degree with minimum of 4 years of relevant experience
  • Medical assistant or nursing background is a plus
  • Minimum of 2 years of sales experience or clinical support/caregiver experience, such as OCN or other.
  • Proficient in Microsoft PowerPoint and Excel; Gmail
  • Fluent in understanding data spreadsheets and technologies
  • Demonstrated ability to quickly learn software and reporting systems
Responsibilities
  • Work with assigned COS to grow, maintain & support existing customers
  • Build relationships with key personnel at assigned Oncology accounts to facilitate unit growth.
  • Analyze and monitor patient testing to ensure that patients remain on the protocol prescribed by the Oncologist.
  • Assess the needs of medical professionals and staff members with a focus on customer support, coordination of logistics, and problem solving
  • Become experts on all Natera Oncology products and processes to maximize effectiveness in the field.
  • Educate medical professionals on the tools and resources that Natera provides to facilitate test order management
  • Utilize and maintain internal reports of key performance indicators (KPIs) related to patient retention and fulfilled order volume.
  • Be a key team player within the sales organization who can partner with internal stakeholders, such as sales reps, patient coordinators, territory managers, etc., to achieve the best outcomes for the patient and the provider.

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their main technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible remotely. In addition to oncology, Natera provides testing for organ health in transplant patients and offers tests for women's health, including family planning and prenatal screening. Their Panorama NIPT has conducted over 2 million tests. Natera's business model involves selling testing kits and services to healthcare providers and patients, often reimbursed by insurance, and they provide genetic counseling services for personalized patient support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

12%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks